New York State Common Retirement Fund’s Climb Bio CLYM Stock Holding History

New York State Common Retirement Fund’s Portfolio CLYM Stock Details CLYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Buy	+12,300	New	+$127K	﹤0.01%	2458
2025 Q2	–	Sell	-10,500	Closed	-$12.8K	–	3374
2025 Q1	$12.8K	Hold	10,500	–	–	﹤0.01%	3048
2024 Q4	$18.9K	Hold	10,500	–	–	﹤0.01%	3046
2024 Q3	$53.4K	Sell	10,500 -2,800	-21%	-$19.8K	﹤0.01%	2841
2024 Q2	$94.6K	Buy	+13,300	New	+$88.5K	﹤0.01%	2891
2022 Q3	–	Sell	-59	Closed	–	–	3477
2022 Q2	$0	Sell	59 -3,300	-98%	-$15.6K	﹤0.01%	3551
2022 Q1	$28K	Hold	3,359	–	–	﹤0.01%	3260
2021 Q4	$35K	Buy	+3,359	New	+$50.1K	﹤0.01%	3269

Other funds holding CLYM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's CLYM Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Climb Bio (CLYM) in Q2 2026: 12,300 shares worth $160K. The stake represents ﹤0.01% of the portfolio and ranks #2458 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in CLYM as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in CLYM in Q4 2021 and has held it in 8 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

New York State Common Retirement Fund held 12,300 shares of Climb Bio worth $160K as of Q2 2026.
Climb Bio was a new New York State Common Retirement Fund position in Q2 2026.
Climb Bio made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2458 holding.
New York State Common Retirement Fund first reported a position in Climb Bio in Q4 2021 and has held it in 8 quarters since.
108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.